← Open Payments lookup

TROY LUNCEFORD: Open Payments

NPI 1194842286 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,295 in 198 payments from 20 companies in 2025. Trend: 2023 $1,664 · 2024 $2,525 · 2025 $2,295

Food & beverage: $2,295
CompanyPaymentsAmount
ABBVIE INC.36$388
Astellas Pharma US Inc11$219
PFIZER INC.21$203
AstraZeneca Pharmaceuticals LP8$201
Novo Nordisk Inc26$198
Axsome Therapeutics, Inc.10$192
Amgen Inc.15$169
Otsuka America Pharmaceutical, Inc.12$169
Aimmune Therapeutics, Inc.15$142
Lilly USA, LLC27$113

Products named: Veozah, VRAYLAR, REXULTI, FARXIGA, ZENPEP, QULIPTA, NURTEC ODT, MOUNJARO.

Industry payments across UT — which companies pay providers there.